Prohledat tento blog

13.11.11

Capecitabine Improves Survival in Advanced Breast Cancer

Capecitabine Improves Survival in Advanced Breast Cancer

Women with advanced breast cancer had similar survival rates, but less toxicity, with capecitabine compared to classical cyclophosphamide, methotrexate, and fluorouracil (CMF) first-line therapy in a randomized trial.
Enhanced by Zemanta

Peritoneal cancer index

Poznámky používá se k hodnocení rozsahu postižení peritoneální dutiny nádorem COLOPEC klinická studie kolorektální karcino...